Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease?

[1]  P. Libby.  Inflammation during the life cycle of the atherosclerotic plaque. , 2021, Cardiovascular research.

[2]  E. Aikawa,et al.  Innate and adaptative immunity: The understudied driving force of heart valve disease. , 2021, Cardiovascular research.

[3]  André F. Rendeiro,et al.  Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis , 2021, Circulation.

[4]  P. Libby,et al.  Targeting inflammation in atherosclerosis — from experimental insights to the clinic , 2021, Nature Reviews Drug Discovery.

[5]  P. Libby.  The changing landscape of atherosclerosis , 2021, Nature.

[6]  L. Joosten,et al.  Trained Immunity: Reprogramming Innate Immunity in Health and Disease. , 2021, Annual review of immunology.

[7]  Johannes G. Reiter,et al.  Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis , 2021, Cell.

[8]  L. Joosten,et al.  Reprogramming of bone marrow myeloid progenitor cells in patients with severe coronary artery disease , 2020, eLife.

[9]  M. Netea,et al.  Trained Immunity in Atherosclerotic Cardiovascular Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[10]  M. Rattazzi,et al.  Current Evidence and Future Perspectives on Pharmacological Treatment of Calcific Aortic Valve Stenosis , 2020, International journal of molecular sciences.

[11]  Balachandar Nedumaran,et al.  Monocytes enhance the inflammatory response to TLR2 stimulation in aortic valve interstitial cells through paracrine up-regulation of TLR2 level , 2020, International journal of biological sciences.

[12]  A. Kutikhin,et al.  Ultrastructural Pathology of Atherosclerosis, Calcific Aortic Valve Disease, and Bioprosthetic Heart Valve Degeneration: Commonalities and Differences , 2020, International journal of molecular sciences.

[13]  G. Hankey,et al.  Colchicine in Patients with Chronic Coronary Disease. , 2020, The New England journal of medicine.

[14]  J. Cornel,et al.  Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy. , 2020, Circulation.

[15]  A. Zeiher,et al.  Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure. , 2020, JAMA cardiology.

[16]  Brian A. Aguado,et al.  Secreted Factors From Proinflammatory Macrophages Promote an Osteoblast-Like Phenotype in Valvular Interstitial Cells , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[17]  E. Lutgens,et al.  Short-term regulation of hematopoiesis by lipoprotein(a) results in the production of pro-inflammatory monocytes. , 2020, International journal of cardiology.

[18]  D. Rizopoulos,et al.  The association of innate and adaptive immunity, subclinical atherosclerosis, and cardiovascular disease in the Rotterdam Study: A prospective cohort study , 2020, PLoS medicine.

[19]  B. Lewis,et al.  An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial. , 2020, JAMA cardiology.

[20]  P. Libby,et al.  Neutrophil Extracellular Traps Participate in Cardiovascular Diseases , 2020, Circulation research.

[21]  B. Nordestgaard,et al.  Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study. , 2020, European heart journal.

[22]  A. Hoischen,et al.  Catecholamines Induce Trained Immunity in Monocytes In Vitro and In Vivo , 2020, Circulation research.

[23]  M. Koschinsky,et al.  Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation , 2020, Circulation research.

[24]  S. Zimmer,et al.  Aortic Valve Stenosis , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[25]  R. Xavier,et al.  Defining trained immunity and its role in health and disease , 2020, Nature Reviews Immunology.

[26]  J. Fuster,et al.  Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease. , 2020, Atherosclerosis.

[27]  M. Dweck,et al.  Pathophysiology of Aortic Stenosis and Future Perspectives for Medical Therapy. , 2020, Cardiology clinics.

[28]  O. Soehnlein,et al.  Neutrophils as regulators of cardiovascular inflammation , 2020, Nature Reviews Cardiology.

[29]  A. Schober,et al.  Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium , 2018, Nature Communications.

[30]  J. Witztum,et al.  Statin therapy increases lipoprotein(a) levels. , 2020, European heart journal.

[31]  Christopher N. Foley,et al.  Genetic Determinants of Lipids and Cardiovascular Disease Outcomes , 2019, Circulation. Genomic and precision medicine.

[32]  Y. Kaiser,et al.  Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis , 2019, Biomolecules.

[33]  R. Diaz,et al.  Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. , 2019, The New England journal of medicine.

[34]  M. Dweck,et al.  Aortic valve stenosis—multimodality assessment with PET/CT and PET/MRI , 2019, The British journal of radiology.

[35]  S. Fichtlscherer,et al.  Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation , 2019, European heart journal.

[36]  L. Joosten,et al.  Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia. , 2019, Cell metabolism.

[37]  A. Kutikhin,et al.  Development of calcific aortic valve disease: Do we know enough for new clinical trials? , 2019, Journal of molecular and cellular cardiology.

[38]  Michael A. Raddatz,et al.  Adaptive Immune Cells in Calcific Aortic Valve Disease. , 2019, American journal of physiology. Heart and circulatory physiology.

[39]  A. Undas,et al.  NETosis is associated with the severity of aortic stenosis: Links with inflammation. , 2019, International journal of cardiology.

[40]  Christopher N. Foley,et al.  Genetic Determinants of Lipids and Cardiovascular Disease Outcomes , 2019, bioRxiv.

[41]  M. Koschinsky,et al.  Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis , 2019, Journal of the American College of Cardiology.

[42]  Z. Mallat,et al.  Targeting the Immune System in Atherosclerosis: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[43]  V. Fuster,et al.  Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI. , 2019, Journal of the American College of Cardiology.

[44]  Xiaochun Ma,et al.  Predictive Roles of Neutrophil-to-Lymphocyte Ratio and C-Reactive Protein in Patients with Calcific Aortic Valve Disease. , 2019, International heart journal.

[45]  M. Dweck,et al.  The Role of Imaging in Measuring Disease Progression and Assessing Novel Therapies in Aortic Stenosis , 2019, JACC. Cardiovascular imaging.

[46]  A. Keech,et al.  Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk: Insights From the FOURIER Trial , 2019, Circulation.

[47]  P. Pibarot,et al.  Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial , 2018, JAMA cardiology.

[48]  K. Koh,et al.  Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease. , 2018, Atherosclerosis.

[49]  R. de Caterina,et al.  Innate and adaptive immunity in atherosclerosis. , 2018, Vascular pharmacology.

[50]  C. García-Rodríguez,et al.  Toll-Like Receptors, Inflammation, and Calcific Aortic Valve Disease , 2018, Front. Physiol..

[51]  A. Durham,et al.  Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness , 2018, Cardiovascular research.

[52]  M. Oosting,et al.  Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming , 2018, Cell.

[53]  H. Crijns,et al.  Calcific aortic valve stenosis: hard disease in the heart , 2017, European heart journal.

[54]  K. Shimada,et al.  An Interleukin-6 Receptor Antibody Suppresses Atherosclerosis in Atherogenic Mice , 2017, Front. Cardiovasc. Med..

[55]  M. Laule,et al.  Levels of Circulating Intermediate Monocytes Decrease after Aortic Valve Replacement in Patients with Severe Aortic Stenosis , 2017, Thrombosis and Haemostasis.

[56]  Y. Bossé,et al.  OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA–NF-&kgr;B pathway , 2017, Cardiovascular research.

[57]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[58]  P. Galuppo,et al.  Intermediate CD14++CD16+ monocytes decline after transcatheter aortic valve replacement and correlate with functional capacity and left ventricular systolic function , 2017, PloS one.

[59]  J. Kuiper,et al.  NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[60]  S. Gabriel,et al.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.

[61]  Fei Li,et al.  The shift of macrophages toward M1 phenotype promotes aortic valvular calcification , 2017, The Journal of thoracic and cardiovascular surgery.

[62]  P. Libby,et al.  Interferon-γ Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves. , 2017, The American journal of pathology.

[63]  F. Fonseca,et al.  Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease. , 2017, Clinical science.

[64]  K. Rayner,et al.  The walking dead: macrophage inflammation and death in atherosclerosis , 2017, Current opinion in lipidology.

[65]  C. Dinarello,et al.  IL-37 Suppresses MyD88-mediated Inflammatory Responses in Human Aortic Valve Interstitial Cells , 2017, Molecular medicine.

[66]  Matthew A. Cooper,et al.  Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.

[67]  R. Pardi,et al.  Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1&bgr; Production , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[68]  J. Cleveland,et al.  Interleukin-37 suppresses the osteogenic responses of human aortic valve interstitial cells in vitro and alleviates valve lesions in mice , 2017, Proceedings of the National Academy of Sciences.

[69]  M. Laule,et al.  Severe Aortic Valve Stenosis in Adults is Associated with Increased Levels of Circulating Intermediate Monocytes , 2017, Journal of Cardiovascular Translational Research.

[70]  Gary Tse,et al.  Animal models of atherosclerosis , 2017, Biomedical reports.

[71]  G. Pasterkamp,et al.  The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction , 2016, European heart journal.

[72]  C. Voermans,et al.  Increased haematopoietic activity in patients with atherosclerosis , 2016, European heart journal.

[73]  S. Crooke,et al.  Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials , 2016, The Lancet.

[74]  L. Joosten,et al.  Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo. , 2016, Atherosclerosis.

[75]  L. Joosten,et al.  Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans , 2016, Circulation.

[76]  E. Shin,et al.  Prognostic Utility of Neutrophil-to-Lymphocyte Ratio on Adverse Clinical Outcomes in Patients with Severe Calcific Aortic Stenosis , 2016, PloS one.

[77]  V. Fuster,et al.  Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability , 2016, Nature Communications.

[78]  B. Nordestgaard,et al.  PCSK9 R46L Loss-of-Function Mutation Reduces Lipoprotein(a), LDL Cholesterol, and Risk of Aortic Valve Stenosis. , 2016, The Journal of clinical endocrinology and metabolism.

[79]  T. Assimes,et al.  The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease , 2016, The Journal of experimental medicine.

[80]  C. Otto,et al.  Calcific aortic stenosis , 2016, Nature Reviews Disease Primers.

[81]  Anita Driessen-Mol,et al.  Age-Dependent Changes in Geometry, Tissue Composition and Mechanical Properties of Fetal to Adult Cryopreserved Human Heart Valves , 2016, PloS one.

[82]  Seung Hyun Lee,et al.  Involvement of Immune Cell Network in Aortic Valve Stenosis: Communication between Valvular Interstitial Cells and Immune Cells , 2016, Immune network.

[83]  I. Bar,et al.  Circulating CD14+ monocytes in patients with aortic stenosis , 2016, Journal of geriatric cardiology : JGC.

[84]  A. Undas,et al.  Presence of B cells within aortic valves in patients with aortic stenosis: Relation to severity of the disease. , 2016, Journal of cardiology.

[85]  Y. Bossé,et al.  Oxidized Phospholipids, Lipoprotein(a), and Progression of Calci fi c Aortic Valve Stenosis , 2017 .

[86]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[87]  G. Maurer,et al.  Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a) , 2015, Journal of clinical lipidology.

[88]  M. Yacoub,et al.  Modulation of Human Valve Interstitial Cell Phenotype and Function Using a Fibroblast Growth Factor 2 Formulation , 2015, PloS one.

[89]  C. Newton-Cheh,et al.  Genome-wide association studies of late-onset cardiovascular disease. , 2015, Journal of molecular and cellular cardiology.

[90]  Barry J. Davis,et al.  Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials , 2015, The Lancet.

[91]  Yu Kataoka,et al.  Impact of statins on serial coronary calcification during atheroma progression and regression. , 2015, Journal of the American College of Cardiology.

[92]  Philip Greenland,et al.  Population-wide trends in aortic stenosis incidence and outcomes. , 2015, Circulation.

[93]  D. Ingram,et al.  Clinical significance of monocyte heterogeneity , 2015, Clinical and Translational Medicine.

[94]  J. Narula,et al.  Early aortic valve inflammation precedes calcification: a longitudinal FDG-PET/CT study. , 2015, Atherosclerosis.

[95]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[96]  A. Franco‐Cereceda,et al.  Ascending aortic dilatation is rarely associated with coronary artery disease regardless of aortic valve morphology. , 2014, The Journal of thoracic and cardiovascular surgery.

[97]  Vilmundur Gudnason,et al.  Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis. , 2014, JAMA.

[98]  T. J. Berkel,et al.  Diet‐induced (epigenetic) changes in bone marrow augment atherosclerosis , 2014, Journal of leukocyte biology.

[99]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[100]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[101]  A. Avcı,et al.  The Relationship between Neutrophil/Lymphocyte Ratio and Calcific Aortic Stenosis , 2014, Echocardiography.

[102]  G. Vorobiof,et al.  Insights Into Aortic Sclerosis and Its Relationship With Coronary Artery Disease , 2014, Journal of the American Heart Association.

[103]  Catherine M. Otto,et al.  Aortic-valve stenosis--from patients at risk to severe valve obstruction. , 2014, The New England journal of medicine.

[104]  P. Kovanen,et al.  Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis. , 2014, Atherosclerosis.

[105]  L. Joosten,et al.  Oxidized Low-Density Lipoprotein Induces Long-Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of Monocytes , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[106]  Xianzhong Meng,et al.  Augmented Osteogenic Responses in Human Aortic Valve Cells Exposed to oxLDL and TLR4 Agonist: A Mechanistic Role of Notch1 and NF-κB Interaction , 2014, PloS one.

[107]  P. Barter,et al.  Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL). , 2014, The American journal of cardiology.

[108]  Y. Bossé,et al.  Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization. , 2014, Journal of the American College of Cardiology.

[109]  M. Sandhu,et al.  Lipoprotein(a) levels, genotype and incident aortic stenosis: a prospective Mendelian randomization study and replication in a case-control cohort , 2013 .

[110]  A. Zallone,et al.  Aortic valvular interstitial cells apoptosis and calcification are mediated by TNF-related apoptosis-inducing ligand. , 2013, International journal of cardiology.

[111]  E. Ingelsson,et al.  Valvular osteoclasts in calcification and aortic valve stenosis severity. , 2013, International journal of cardiology.

[112]  K. Moore,et al.  Macrophages in atherosclerosis: a dynamic balance , 2013, Nature Reviews Immunology.

[113]  R. Schnabel,et al.  Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: a meta-analysis of adjusted observational results. , 2013, International journal of cardiology.

[114]  G. Norata,et al.  LOX-1, OxLDL, and Atherosclerosis , 2013, Mediators of inflammation.

[115]  J. Cleveland,et al.  Interleukin-1 Beta induces an inflammatory phenotype in human aortic valve interstitial cells through nuclear factor kappa Beta. , 2013, The Annals of thoracic surgery.

[116]  Magdi H Yacoub,et al.  Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. , 2013, The American journal of pathology.

[117]  Kathleen F. Kerr,et al.  Genetic associations with valvular calcification and aortic stenosis. , 2013, The New England journal of medicine.

[118]  J. Eikelboom,et al.  Low-dose colchicine for secondary prevention of cardiovascular disease. , 2013, Journal of the American College of Cardiology.

[119]  Gretchen J. Mahler,et al.  Inflammatory Cytokines Promote Mesenchymal Transformation in Embryonic and Adult Valve Endothelial Cells , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[120]  A. Gotlieb,et al.  The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops. , 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[121]  Y. Bossé,et al.  Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease , 2013, Inflammation.

[122]  M. Dweck,et al.  Calcific aortic stenosis: a disease of the valve and the myocardium. , 2012, Journal of the American College of Cardiology.

[123]  D. Fliser,et al.  CD14 CD16 Monocytes Independently Predict Cardiovascular Events , 2012 .

[124]  E. V. van Beek,et al.  Assessment of Valvular Calcification and Inflammation by Positron Emission Tomography in Patients With Aortic Stenosis , 2012, Circulation.

[125]  C. Stefanadis,et al.  The role of nitric oxide on endothelial function. , 2012, Current vascular pharmacology.

[126]  K. J. Grande-Allen,et al.  Calcific Aortic Valve Disease : Not Simply a Degenerative Process A Review and Agenda for Research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group , 2012 .

[127]  T. Brady,et al.  Imaging of the aortic valve using fluorodeoxyglucose positron emission tomography increased valvular fluorodeoxyglucose uptake in aortic stenosis. , 2011, Journal of the American College of Cardiology.

[128]  E. Aikawa,et al.  Molecular Imaging Insights Into Early Inflammatory Stages of Arterial and Aortic Valve Calcification , 2011, Circulation research.

[129]  Jonathan T Butcher,et al.  Aortic valve disease and treatment: the need for naturally engineered solutions. , 2011, Advanced drug delivery reviews.

[130]  M. Budoff,et al.  Stages of systemic hypertension and blood pressure as correlates of computed tomography-assessed aortic valve calcium (from the Multi-Ethnic Study of Atherosclerosis). , 2011, The American journal of cardiology.

[131]  Silvano Sozzani,et al.  Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.

[132]  F. Blanco-Favéla,et al.  Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response. , 2010, Human immunology.

[133]  S. Siu,et al.  Bicuspid aortic valve disease. , 2010, Journal of the American College of Cardiology.

[134]  V. Fuster,et al.  Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? , 2010, Journal of the American College of Cardiology.

[135]  R. Cury,et al.  Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium. , 2010, Journal of the American College of Cardiology.

[136]  Christopher A. Durst,et al.  Age-related changes in material behavior of porcine mitral and aortic valves and correlation to matrix composition. , 2010, Tissue engineering. Part A.

[137]  K. Teo,et al.  Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis: Results of the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) Trial , 2010, Circulation.

[138]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[139]  K. Moore,et al.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer , 2009, Nature Immunology.

[140]  T. Akasaka,et al.  Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. , 2009, Journal of the American College of Cardiology.

[141]  S. Young,et al.  Lowering Plasma Cholesterol Levels Halts Progression of Aortic Valve Disease in Mice , 2009, Circulation.

[142]  Craig A Simmons,et al.  Identification and characterization of aortic valve mesenchymal progenitor cells with robust osteogenic calcification potential. , 2009, The American journal of pathology.

[143]  Ajit P Yoganathan,et al.  Altered Shear Stress Stimulates Upregulation of Endothelial VCAM-1 and ICAM-1 in a BMP-4– and TGF-&bgr;1–Dependent Pathway , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[144]  A. Newby.  Metalloproteinase Expression in Monocytes and Macrophages and its Relationship to Atherosclerotic Plaque Instability , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[145]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[146]  J. Chambers,et al.  Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. , 2008, The New England journal of medicine.

[147]  G. Feuchtner,et al.  Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg). , 2008, The American journal of cardiology.

[148]  J. Després,et al.  Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[149]  B. Psaty,et al.  Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study. , 2007, Journal of the American College of Cardiology.

[150]  Ralph Weissleder,et al.  Multimodality Molecular Imaging Identifies Proteolytic and Osteogenic Activities in Early Aortic Valve Disease , 2007, Circulation.

[151]  Ahmed Tawakol,et al.  In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. , 2006, Journal of the American College of Cardiology.

[152]  M. C. Epistolato,et al.  Biological features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: two different sites of the same disease? , 2006, American journal of clinical pathology.

[153]  I. Palacios,et al.  Relation of circulating C-reactive protein to progression of aortic valve stenosis. , 2006, The American journal of cardiology.

[154]  Rosario V. Freeman,et al.  Spectrum of Calcific Aortic Valve Disease: Pathogenesis, Disease Progression, and Treatment Strategies , 2005, Circulation.

[155]  R. Prescott,et al.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.

[156]  R. de Caterina,et al.  Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. , 2004, Journal of the American College of Cardiology.

[157]  S. Hagl,et al.  Receptor activator of nuclear factor κB ligand and osteoprotegerin regulate aortic valve calcification , 2004 .

[158]  R. Detrano,et al.  Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[159]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[160]  A. Pietroiusti,et al.  C-reactive protein is increased in patients with degenerative aortic valvular stenosis. , 2001, Journal of the American College of Cardiology.

[161]  Emile R. Mohler,et al.  Bone Formation and Inflammation in Cardiac Valves , 2001, Circulation.

[162]  L. Ferrucci,et al.  Cardiovascular Disease, Interleukin-6, and Risk of Mortality in Older Women: The Women’s Health and Aging Study , 2001, Circulation.

[163]  D. Kelleher,et al.  Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. , 2000, Journal of the American College of Cardiology.

[164]  J. Shirani,et al.  Matrix metalloproteinase expression in nonrheumatic aortic stenosis. , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[165]  J. Thomas,et al.  Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. , 2000, Journal of the American College of Cardiology.

[166]  P. Ridker,et al.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. , 2000, Circulation.

[167]  R. Bergström,et al.  Observed and relative survival after aortic valve replacement. , 2000, Journal of the American College of Cardiology.

[168]  J. Thyberg,et al.  Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[169]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[170]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[171]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[172]  Bonnie K. Lind,et al.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. , 1997, Journal of the American College of Cardiology.

[173]  C. Otto,et al.  Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[174]  A. Gown,et al.  Characterization of the Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis: Histological and Immunohistochemical Studies , 1994, Circulation.

[175]  M. Thubrikar,et al.  Patterns of calcific deposits in operatively excised stenotic or purely regurgitant aortic valves and their relation to mechanical stress. , 1986, The American journal of cardiology.